Cost-effectiveness of enzyme replacement therapy for Fabry disease

BACKGROUND: The cost-effectiveness of enzyme replacement therapy (ERT) compared to standard medical care was evaluated in the Dutch cohort of patients with Fabry disease. METHODS: Cost-effectiveness analysis was performed using a life-time state-transition model. Transition probabilities, effectiven...

Descripción completa

Detalles Bibliográficos
Autores principales: Rombach, Saskia M, Hollak, Carla EM, Linthorst, Gabor E, Dijkgraaf, Marcel GW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598841/
https://www.ncbi.nlm.nih.gov/pubmed/23421808
http://dx.doi.org/10.1186/1750-1172-8-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598841/
https://www.ncbi.nlm.nih.gov/pubmed/23421808
http://dx.doi.org/10.1186/1750-1172-8-29

Ejemplares similares